Traditionally, the coronary circulation was divided into two arterial compartments: the conduit and the resistive vessels. It has become apparent that there is substantial heterogeneity in resistive vessels with respect to the regulation of coronary flow, which is modified by the perfusion pressure, flow, myocardial metabolism, and ventricular wall tension. Early in the atherosclerotic process, the ability of the coronary resistive vessels to vasodilate maximally under physiological or pharmacological stress is impaired,' often in the presence of coronary risk factors and before the development of angiographically apparent dis- Although it was first considered that most resistance to coronary flow resided in arterioles < 100 pm, much resistance is present in larger arterioles and small arteries up to 300 pm in diameter (90% in vessels < 300 pm).7 In the cat, 50% of coronary resistance is in vessels > 100,um (25% in vessels > 170 pm) under basal conditions.8 As 10% of resistance is in the venous compartment, this leaves about 40% of resistance in the vessels < 100 pm. Pharmacological vasodilatation can alter the distribution of resistance; dipyridamole and adenosine reduce resistance in resistive vessels < 150-170 pm,9 whereas, papaverine preferentially vasodilates larger coronary arterioles and small coronary arteries (> 200 pm).7 Thus coronary resistance coexists in different arteriolar compartments and its distribution may change according to the perfusion pressure and local metabolic environment.
The distribution of the coronary resistance The resistive vessels match myocardial blood flow to variable myocardial energy requirements and to myocardial demand when the coronary perfusion pressure varies, such that myocardial oxygen extraction is virtually constant over a wide range of cardiac work and perfusion pressures. Coronary resistance is influenced both by extrinsic factors such as myocardial compression and by intrinsic factors such as tissue metabolism and neural and humoral influences. The influence of myocardial compression means that coronary blood flow ceases when the perfusion pressure is low but still substantially above coronary venous pressure. 6 Although it was first considered that most resistance to coronary flow resided in arterioles < 100 pm, much resistance is present in larger arterioles and small arteries up to 300 pm in diameter (90% in vessels < 300 pm).7 In the cat, 50% of coronary resistance is in vessels > 100,um (25% in vessels > 170 pm) under basal conditions.8 As 10% of resistance is in the venous compartment, this leaves about 40% of resistance in the vessels < 100 pm. Pharmacological vasodilatation can alter the distribution of resistance; dipyridamole and adenosine reduce resistance in resistive vessels < 150-170 pm,9 whereas, papaverine preferentially vasodilates larger coronary arterioles and small coronary arteries (> 200 pm).7
Thus coronary resistance coexists in different arteriolar compartments and its distribution may change according to the perfusion pressure and local metabolic environment.
The heterogeneity of the coronary resistive vessels Myocardial tissue perfusion is in part modulated by autoregulation-the intrinsic ability to maintain myocardial flow relatively constant after changes in perfusion pressure-and by tissue metabolism. Autoregulation may be influenced by extrinsic factors such as autonomic nervous system activity and circulating hormones, and occurs between perfusion pressures of 70 and 130 mm Hg.'0
In the presence of a functionally significant coronary stenosis and with a perfusion pressure within the autoregulatory range, coronary flow is maintained because of vasodilatation of the resistive vessels < 100 pm diameter, with the magnitude of vasodilatation being inversely proportional to the diameter." At a perfusion pressure below the autoregulatory range, although the vessels < 100,um dilate maximally, vessels > 100 pm decrease Schematic representation of a conduit coronary artery and prearteriolar and arteriolar vessels with patchily distributed pre-arteriolar constriction in control conditions (A, upper panel) and during arteriolar vasodilatation (B, upper panel). In this functional classification, conduit coronary arteries do not have appreciable flow resistance, arteriolar vessels are responsible for the metabolic autoregulation of coronary bloodflow and prearteriolar vessels are those segments interposed between conductive arteriolar vessels with appreciable coronary flow resistance that are responsible for maintaining perfusion pressure at the origin of arterioles within optimal levels. The vasodilatory reserve of arterioles distal to constricted prearteriolar vessels is reduced because they are already dilated to preserve rest flow. In conduit coronary arteries, the pressure remains similar to aortic pressure, but decreases progressively across prearteriolar vessels in proportion to their degree of constriction (A, lower panel). During metabolic or pharmacological arteriolar vasodilatation, the pressure drop increases only slightly distal to some prearteriolar vessels (a,, a2, b) because vasodilatation related to flow-mediated release of endothelium derived relaxingfactor compensates nearly completely for the increased flow. The pressure drop increases markedly across more constricted pre-arteriolar vessels (b,, c,, c) (B, lower panel). Steal can develop when an increase in flow through c2 causes a pressure decrease at the branching point distal to the constricted segment c, so that the driving pressure becomes insufficient to perfuse adequately the most constricted branch c, and bloodflow (as indicated by arrows) can become lower than during rest conditions. The possibility offlow steal is greatly enhanced if branch c2 perfuses subepicardial layers of the ventricular wall with a greaterflow reserve and if branch c, perfuses the subendocardial layers with a smallerflow reserve. At the end of the pre-arteriolar vessels with the most marked increase in tone In a recent study of the microcirculation in normal and atherosclerotic monkeys, serotonin (an endothelium-dependent vasodilator) decreased coronary resistance in normal animals but increased large artery and microvascular resistance in atherosclerotic animals." Given that the response to adenosine was no different in the two groups, atherosclerosis did not impair the vascular smooth muscle response, but was associated with endothelial dysfunction. In another study, isolated cannulated coronary arterioles (30-70,um) from atherosclerotic and normal pigs were studied using the endothelial-dependent agents, ADP, serotonin, and histamine.34 These agents induced vasodilatation in only 20-30% of controls. The response to flow was abolished in denuded normal arterioles and in those from atherosclerotic animals. However, administration of large doses of L-arginine restored normal vasodilator responses to all stimuli. In hypercholesterolaemic animals, the availability of L-arginine can be a rate-limiting factor in endothelial-dependent vasorelaxation in response to receptor-mediated agonists such as acetylcholine.5 When D-arginine was used as a control, the oxidised low density lipoprotein (LDL)-cholesterol interfered with receptor-mediated release of L-arginine from intracellular stores or its synthesis in endothelial cells.'6 Thus it may be that altered resistive vessel responsiveness developing with large vessel disease involves an impairment of the synthesis/release of NO.34 In humans, normal epicardial vessels dilate in response to increasing flow through resistive vessel dilatation caused by intracoronary papaverine, but this response is reduced in atherosclerotic arteries.'7 When three different endothelium-mediated stimuli-acetylcholine, cold pressor stress, and increasing blood flow-were used there was progressive impairment of epicardial vasodilatation with vasoconstriction only to acetylcholine in subjects with hypercholesterolaemia alone, with vasoconstriction to both acetylcholine and cold pressor in patients with a normal artery but with disease elsewhere, and abolition of vasodilatation to all three stimuli in patients with angiographic wall irregularities.2 In the microcirculation, vasodilatation to acetylcholine was markedly reduced in patients with smooth arteries and hypercholesterolaemia. In an angiographically normal artery in patients with disease elsewhere, there was also a reduced vasodilator response, particularly when LDL-cholesterol was high. However, compared with the control group, flow-dependent vasodilatation was lower only in those with macroscopic disease.2
In patients with hypercholesterolaemia and minimal wall irregularities, intracoronary Larginine infusion before acetylcholine can restore the vasodilator response to that in controls.' In both groups the papaverine response was unimpaired and basal coronary flow was unaffected by an L-arginine infusion, implying that it was during vasodilatation that the deficit in NO production was most prominent. 3 Thus there is progressive impairment of endothelium-dependent vasodilatation in patients at different stages of the atherosclerotic process.
The assessment of resistive vessel function in clinical studies is dependent on measuring changes in coronary or myocardial blood flow. In patients with comparable coronary stenoses, resistive vessel dysfunction is only one variable along with loading conditions, intramyocardial wall tension, and collaterals in determining absolute myocardial flow. '8 Nonetheless, there are several clinical models in coronary disease which suggest the presence of resistive vessel dysfunction. After successful angioplasty, the coronary flow reserve may be unchanged from pre-angioplasty values in a significant number of patients,'9 and impaired for up to 24 hours,40 perhaps owing to a combination of platelet activation, vasoconstrictor release, and debris embolisation. Basal flow recovers over several days, suggesting a chronic adaptation pre-angioplasty to the reduction in coronary perfusion pressure. In the absence of restenosis, the recovery of resistive vessel function is sustained after three months with a coronary vasodilator reserve similar to remote regions in patients with stable disease.40 However, the mechanisms underlying the impaired vasodilator response early after angioplasty remain uncertain, although in some patients it may reflect suboptimal epicardial dilatation.
There 47 There is a direct relation between the epicardial and the microcirculatory vasodilator response in these patients, such that the increase in coronary flow with acetylcholine correlates directly with the increase in epicardial coronary diameter. Furthermore, infusion of L-arginine increases the blood flow response to acetylcholine, implying significant reversible endothelial dysfunction in the coronary microcirculation, with the greatest effect of L-arginine in vessels without increased intimal thickening. 47 The common feature in these studies is the presence of endothelial dysfunction early in the atherosclerotic process and its modulation by L-arginine delivery and oxidised LDL-cholesterol. These observations reinforce the association between endothelial function, cholesterol subfractions, and plaque load in the determination of both the epicardial and microvascular vasodilator responses in humans.
Conclusions
Resistive vessels may be regarded as two distinct groups: a proximal compartment controlled by flow, distending pressure, and myogenic tone and modulated by the autonomic nervous system and endothelial function; and a distal compartment influenced mainly by the perfusion pressure at the origin of the vessel and by myocardial metabolism. There is already increasing evidence for inappropriate vasomotor tone in the larger resistive vessels in hypertension,48 cardiac transplantation,4749 and in syndrome X.50 It is possible that both the effect of the early atherosclerotic process on endothelial function and alterations in sympathetic drive could also account for such abnormalities in patients with coronary disease. However, the clinical implications of these abnormalities remain uncertain.
